No Data
Dongxing Securities: The government's procurement of green building materials is expanding, accelerating the optimization of the supply side.
The government's increase in the scope and intensity of procurement for green building materials aligns with the industry's policy of continuously eliminating outdated productive capacity.
Declining Stock and Solid Fundamentals: Is The Market Wrong About Shandong Pharmaceutical Glass Co.Ltd (SHSE:600529)?
Sinolink: Several central and state-owned enterprises in the building materials sector, including Beixin and Kaisheng, have released incentive plans that emphasize the direction of Market Cap management.
From the action plans of state-owned and centrally administered enterprises that are being progressively implemented, the overall process has accelerated, reflecting the confidence of central enterprises in high-quality development and operational capabilities, and it is expected to play a leading role in specific segments of the Industry.
Shandong Pharmaceutical Glass (600529.SH): The indirect controlling shareholder may change.
Shandong Pharmaceutical Glass (600529.SH) announced that on December 30, 2024, the company received notice from its controlling Shareholder Shan...
While Shareholders of Shandong Pharmaceutical GlassLtd (SHSE:600529) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown
Debon Securities: The scale of borosilicate pharmaceutical glass is continuously expanding. Pay attention to the improvement in profitability within the industry as costs decline.
National centralized procurement promotes the adoption of pharmaceuticals with medium borosilicate packaging, expanding the market size of medium borosilicate pharmaceutical glass.
No Data
